In this context, Vanksen has chosen to publish its latest Pharma edition study: « Empowering Patients and Health Professionals through Digital Content ».

Its goal: to help industry professionals ask the right questions in their digital marketing projects and, at the same time, inspire them through the experiences of prominent experts in the field and a case study that allows the practical application of all the insights presented in this study.

“This study and its case study perfectly embody what the Vanksen North Star represents: guiding our clients and effectively supporting them in the activation of all the digital levers at their disposal.” – Cécile Lorenzini, Managing Partner

An international approach and a practical implementation inherent to Vanksen's DNA.

The study provides a comprehensive overview of the digital landscape in the pharmaceutical industry: its best practices, marketing strategies, legal and ethical constraints. To obtain a holistic view of the trends shaping the sector, Vanksen experts have chosen to simultaneously analyze two market dynamics:

• On one side, French actors who must navigate within a strict legal framework ;
• On the other side, North American trends where marketing and healthcare evolve more freely.

More than just deciphering the differences between these two markets, the study envisions how they can mutually enrich each other through a case study designed to address an existing issue.

By leveraging all of the agency's resources, from SEO to UX, including Strategic Consulting, Design, Social Listening, IP, and Media, Vanksen's experts have envisioned a platform that demonstrates, step by step, the thought process, design, and deployment of a solution in the European context, augmented by the latest trends in the North American markets.

« We were thrilled to collaborate on such an inspiring case study. We believe this exercise will highlight the best practices to apply to these types of digital projects. » – Nesem Ertan, Creative Strategist

Discover the study and its case study without delay.

The study is available in French and English at the following URLs:

• FR : https://study.vanksen.com/pharma/fr
• UK : https://study.vanksen.com/pharma